Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
Armata Pharmaceuticals, Inc. (APHB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/12/2023 |
4
| Innoviva, Inc. (10% Owner) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Bought options to buy
@ $1.52, valued at
$0 |
|
| 04/15/2022 |
4
| Peterson Todd C. (Director) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 33,000 options to buy
@ $5.11, valued at
$168.6k
|
|
| 04/15/2022 |
4
| Patrick Todd (Director) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 33,000 options to buy
@ $5.11, valued at
$168.6k
|
|
| 04/15/2022 |
4
| Schlesinger Sarah J. (Director) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 33,000 options to buy
@ $5.11, valued at
$168.6k
|
|
| 04/15/2022 |
4
| Kramer Robin (Director) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 33,000 options to buy
@ $5.11, valued at
$168.6k
|
|
| 04/15/2022 |
4
| Odysseas Kostas D (Director) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 33,000 options to buy
@ $5.11, valued at
$168.6k
|
|
| 04/15/2022 |
4
| PATTI JOSEPH M (Director) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 33,000 options to buy
@ $5.11, valued at
$168.6k
|
|
| 04/15/2022 |
4
| Haimovitz Jules (Director) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 33,000 options to buy
@ $5.11, valued at
$168.6k
|
|
| 04/15/2022 |
4
| Morris Duane Alfred (VP of Operations) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 41,000 options to buy
@ $5.11, valued at
$209.5k
|
|
| 04/15/2022 |
4
| Varnum Brian (President and CEO) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 240,000 options to buy
@ $5.11, valued at
$1.2M
|
|
| 04/01/2022 |
4
| Innoviva, Inc. (10% Owner) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Bought 5,385,208 shares
@ $5, valued at
$26.9M
Bought options to buy
@ $5, valued at
$0 |
|
| 02/11/2022 |
4
| Innoviva, Inc. (10% Owner) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Bought 3,614,792 shares
@ $5, valued at
$18.1M
Bought 1,807,396 options to buy
@ $5, valued at
$9M
|
|
| 11/01/2021 |
4
| Innoviva, Inc. (10% Owner) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Bought 1,212,122 shares
@ $3.3, valued at
$4M
|
|
| 08/03/2021 |
4
| Varnum Brian (CEO) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 125,000 options to buy
@ $3.82, valued at
$477.5k
|
|
| 06/09/2021 |
4
| Schlesinger Sarah J. (Director) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 28,000 options to buy
@ $4.29, valued at
$120.1k
|
|
| 06/09/2021 |
4
| Peterson Todd C. (Director) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 28,000 options to buy
@ $4.29, valued at
$120.1k
|
|
| 06/09/2021 |
4
| PATTI JOSEPH M (Director) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 28,000 options to buy
@ $4.29, valued at
$120.1k
|
|
| 06/09/2021 |
4
| Kramer Robin (Director) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 28,000 options to buy
@ $4.29, valued at
$120.1k
|
|
| 06/09/2021 |
4
| Odysseas Kostas D (Director) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 28,000 options to buy
@ $4.29, valued at
$120.1k
|
|
| 04/05/2021 |
4
| Haimovitz Jules (Director) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $4.74, valued at
$142.2k
|
|
| 03/26/2021 |
4
| Varnum Brian (President and CDO) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 112,000 options to buy
@ $5.14, valued at
$575.7k
|
|
| 03/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/26/2021 |
4
| Morris Duane Alfred (VP of Operations) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 28,000 options to buy
@ $5.14, valued at
$143.9k
|
|
| 03/26/2021 |
4
| Martin Steven Robert (CFO) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 56,000 options to buy
@ $5.14, valued at
$287.8k
|
|
| 03/17/2021 |
4
| Innoviva, Inc. (10% Owner) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Bought 4,285,935 shares
@ $3.25, valued at
$13.9M
Bought 4,285,935 options to buy
@ $3.25, valued at
$13.9M
|
|
| 01/28/2021 |
4
| Innoviva, Inc. (10% Owner) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Bought 1,867,912 shares
@ $3.25, valued at
$6.1M
Bought 1,867,912 options to buy
@ $3.25, valued at
$6.1M
|
|
| 12/09/2020 |
4
| Patrick Todd (CEO) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 23,000 options to buy
@ $3.15, valued at
$72.5k
|
|
| 12/09/2020 |
4
| PATTI JOSEPH M (Director) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 23,000 options to buy
@ $3.15, valued at
$72.5k
|
|
| 12/09/2020 |
4
| Peterson Todd C. (Director) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 23,000 options to buy
@ $3.15, valued at
$72.5k
|
|
| 12/09/2020 |
4
| Morris Duane Alfred (VP of Operations) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 23,000 options to buy
@ $3.15, valued at
$72.5k
|
|
| 12/09/2020 |
4
| Kramer Robin (Director) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $3.15, valued at
$94.5k
|
|
| 12/09/2020 |
4
| Martin Steven Robert (CFO) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 23,000 options to buy
@ $3.15, valued at
$72.5k
|
|
| 12/09/2020 |
4
| Schlesinger Sarah J. (Director) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 23,000 options to buy
@ $3.15, valued at
$72.5k
|
|
| 12/09/2020 |
4
| Varnum Brian (President and CDO) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 23,000 options to buy
@ $3.15, valued at
$72.5k
|
|
|
|
|